CD7+ T-ALL/LBL

Clinical trials for CD7+ T-ALL/LBL explained in plain language.

Never miss a new study

Get alerted when new CD7+ T-ALL/LBL trials appear

Sign up with your email to follow new studies for CD7+ T-ALL/LBL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Engineered immune cells take aim at stubborn leukemia after transplant

Disease control Recruiting now

This early-stage trial tests a new treatment called CD7-targeted CAR-T cells for people with T-lymphoblastic leukemia or lymphoma that remains after a stem cell transplant. The therapy uses a patient's own or a donor's immune cells, modified to find and destroy cancer cells. The …

Matched conditions: CD7+ T-ALL/LBL

Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

CD7+ T-ALL/LBL

Get alerted when new CD7+ T-ALL/LBL trials appear

Engineered immune cells take aim at stubborn leukemia after transplant